PARP inhibitors: enhancing efficacy through rational combinations

D Bhamidipati, JI Haro-Silerio, TA Yap… - British journal of cancer, 2023 - nature.com
Poly (ADP-ribose) polymerase inhibitors (PARPi) have significantly changed the treatment
landscape for tumours harbouring defects in genes involved in homologous repair (HR) …

Role of K63-linked ubiquitination in cancer

L Cao, X Liu, B Zheng, C Xing, J Liu - Cell death discovery, 2022 - nature.com
Ubiquitination is a critical type of post-translational modifications, of which K63-linked
ubiquitination regulates interaction, translocation, and activation of proteins. In recent years …

Annual review of PROTAC degraders as anticancer agents in 2022

X Wang, ZL Qin, N Li, MQ Jia, QG Liu, YR Bai… - European Journal of …, 2024 - Elsevier
Following nearly two decades of development, significant advancements have been
achieved in PROTAC technology. As of the end of 2022, more than 20 drugs have entered …

Synthesis and biological evaluation of a tumor-selective degrader of PARP1

C Pu, S Wang, D Luo, Y Liu, X Ma, H Zhang… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors show potent antiproliferative
activity in treatment with triple-negative breast cancer (TNBC) when combined with …

Deficiency of ligase IV leads to reduced NHEJ, accumulation of DNA damage, and can sensitize cells to cancer therapeutics

N Kumari, H Antil, S Kumari, SC Raghavan - Genomics, 2023 - Elsevier
Ligase IV is a key enzyme involved during DNA double-strand breaks (DSBs) repair through
nonhomologous end joining (NHEJ). However, in contrast to Ligase IV deficient mouse cells …

Identification of collateral sensitivity and evolutionary landscape of chemotherapy-induced drug resistance using cellular barcoding technology

N Danisik, KC Yilmaz, A Acar - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: One of the most significant challenges impeding cancer treatment effectiveness
is drug resistance. Combining evolutionary understanding with drug resistance can pave the …

Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma

N Zuo, L Ma, T Liu, W Hu, Y Luo, H Meng, Q Ren… - Oral Oncology, 2023 - Elsevier
Objectives Human papillomavirus (HPV) positive head and neck squamous cell carcinoma
(HNSCC) showed a considerably better prognosis with greater cisplatin sensitivity …

[HTML][HTML] Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease

R Ranganathan, G Sapozhnikov, W Ni, S Li… - Translational Medicine of …, 2023 - Elsevier
The underlying molecular mechanisms associated with sporadic Alzheimer's disease (AD),
a progressive neurodegenerative disease, are not yet fully understood. Adult neurons are …

Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies

S Lukácsi, G Munkácsy… - Integrative Cancer …, 2024 - journals.sagepub.com
Hyperthermia, the raising of tumor temperature (≥ 39° C), holds great promise as an
adjuvant treatment for cancer therapy. This review focuses on 2 key aspects of hyperthermia …

Transient HR enhancement by RAD51-stimulatory compound confers protection on intestinal rather than hematopoietic tissue against irradiation in mice

Z Lu, D Chen, N Zhang, Z Zheng, Z Zhou, G Liu, J An… - DNA repair, 2024 - Elsevier
DNA double-strand breaks (DSBs) are cytotoxic lesions that compromise genomic integrity
and trigger cell death. Homologous recombination (HR) is a major pathway for repairing …